Ваша жизнь в ваших руках. Как понять, победить и предотвратить рак груди и яичников

42. Leonard, Rodney E., 1995. Codex at the Crossroads: Conflict on Trade Health. Nutrition Week, Vol. 25, № 26, 14 July, pp. 4–5, Nutrition Week is published by the Community Nutrition Institute, 910 17^th Street, N.W, Suite 413, Washington DC 20006.

43. The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating 10 Public Health – Outcome of discussions,mt/comm/dg24/health/ sc/scv/ out 19_en.html

44. D’Ercole, J.A., Underwood, L.E. and Van Wyk, J.J., 1977. Serum Somatomedin-C in hypopituaritism and in other disorders of growth./. Pediatr, 90, 3, 375–381. See also Cullen, K.J. and others, 1990. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Research, vol. 50, pp. 48–53.

45. De Leon, D.D., Wilson, D.M., Powers, M. and Rosenfeld, R.G., 1992. Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells. Growth Factors, 6, 327–336.

46. Peyrat, J.P., Bonneterre, J. and Hecquet, B. and others, 1993. Plasma insulin-like growth factor 1 (IGF-1) concentrations in human breast cancer. Eur J Cancer, 29A, 4, 492–497.

47. Peyrat, J.P., Bonneterre, J. and Hecquet, B. and others, 1993. Plasma insulin-like growth factor 1 (IGF-1) concentrations in human breast cancer. Eur J Cancer, 29A, 4, 492–497.

48. Musgrove, E.A. and Sutherland, R.I., 1993. Acute effects of growth factors on T471 breast cancer cell cycle progression, Eur J Cancer, 29 A, 16, 2273–2279.

49. Heldrin, C.N. and Westermark, B., 1984. Growth factors: mechanism of action and relation to oncogenes. Cell, 37:9, 20.

50. Macaulay, V. М., 1992. Insulin-like growth factors and cancer. Br J Cancer, 65, 311–320.

51. Underwood, L.E., D’Ercole, J.A. and Van Wyk, J.J., 1980. So-matomedin-C and the assessment of growth. Fed ClinN Amer,

27, 4, 771–782, and Perdue, J.F., 1984. Chemistry, structure and function of insulin-like growth factors and their receptors: a review. Can J Biochem Cell Bio., 62, 1237–1245.

52. Outwater, J.L., Nicholson, A, and Barnard, N., 1997. Dairy products and breast cancer; the IGF-1 estrogen, and bGH hypothesis. Medical Hypotheses, 48, 453–461.

53. The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating 10 Public Health – Outcome of discussions.sc/scv/ outl 9_en.html

54. Council on Scientific Affairs, American Medical Association, Biotechnology and the American Agricultural Industry, 1991. Journal of the American Medical Association (JAMA), 265, 11, 20 March, p. 1433.

55. Mepham, T.B. and Schonfield, P.N., 1995. Health Aspects of BST Milk, prepared for the International Dairy Federation Nutrition Week conference in Paris, France, June 1995.

56. Challacombe. D.N. and Wheeler, E.E., 1994. Safety of milk from cows treated with bovine somatotropin. Lancet, 344, 17 September, p. 815.

57. Sell, C., Rubin, R. and Baserga, R., 1995. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-in-duced apoptosis. Cancer Research, Jan 15, 55(2), 303–306.

58. Burton, Jeanne L. and others, 1994. A review of bovine growth hormone, Canadian Journal of Animal Science, 74, 167–201.

59. Xian, C., 1995. Degradation of IGF-1 in the Adult Rat Gastrointestinal Tract is limited by a Specific Antiserum of the Dietary Protein Casein .Journal of Endocrinology, 146, 2, 1 August, p. 215, and Thornburg, W and others, 1984. Gastrointestinal absorption of epidermal growth factor in suckling rats. American Journal of Physiology, 246, G80-G85.

60. Outwater, J.L., Nicholson, A. and Barnard, N., 1997. Dairy products and breast cancer; the IGF-1 estrogen, and bGH hypothesis. Medical Hypotheses, 48, 453–461.

61. Harasuchi, S., Good, R.A., Engelman, R.W and Day, N.K., 1992. Human prolactin regulates transfected MMTV LTR-di-rected gene expression in a human breast-carcinoma cell line through synergistic interaction with steroid hormones. Int J Cancer, 52, 923–933.

62. Clevenger, C,V, Chang, WF., Ngo, W, Pasha, T.L., Montone, K.T. And Tomaszewski, J. E., 1995. Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop .Am J Pathol, 146, 695–705.

63. Vonderhaar B.K., 1989. Estrogens are not required for prolactin induced growth of MCF-7 human breast cancer cells. Cancer Lett, A7, 105–110.

64. http://www.shef.ac.uk/uni/academic/a-c/csi/1997/pir2.html

65. Lochnan, H.A. and others, 1995. Functional activity of the human prolactin receptor and its ligands. Mol. Cell. Endocrinol, 114, 91–99.

66.001/ slides/introduction.html